Access and Evidence
VBCs: Are They Working?
Are value-based contracts actually improving patient access to new medicines?
eyeforpharma is now Reuters Events - LEARN MORE
More Access and Evidence Articles
Access and Evidence
Calling the Shots?
How influential are the value assessments from bodies like ICER?
Access and Evidence
Value-Based Contracting: Do We Have The Data?
Deals have been signed. Promises have been made. But are companies delivering the goods?
Access and Evidence
How To Illustrate Your RWE To Payers
Data visualization tools are demystifying real-world evidence.
Access and Evidence
American Healthcare System 1 - 0 Europe
When it comes to pricing and access, the European healthcare system is losing.
Access and Evidence
Working with HTAs: It’s Your Move
European HTA bodies have signaled that they want greater and earlier dialogue with pharma but is their call being answered?
Access and Evidence
Value: A Balancing Act
When it comes to proving the value of a new medicine, pharma has to strike the right balance
Access and Evidence
Can Payers Trust Our Data?
Analyses from RWD are playing an increasingly important role, but will payers accept pharma’s figures?
Access and Evidence
Diving for Data
Finding the right data to underpin outcome-based contracts is not as easy as it looks